Stress-resistance switch (FOXO1)
Insulin-suppressed lipase transcription
Also searched as Insulin-suppressed lipase transcription.
You want to know it exists rather than to push it. It is named alongside the growth sensor as a route by which insulin lowers production of the rate-limiting lipase — evidence that the fed state does not rely on a single mechanism to hold fat in place. The source is explicit that this area is unsettled: the detailed mechanisms of insulin's suppression are described as controversial and incomplete.
In depth
A transcription factor insulin uses to reach the same lipase from another direction.
What drives it
Insulin sensitivity increases it.
'Through this pathway both insulin and beta-adrenergic signaling control phosphorylation of FOXO1' (PMC6792037, human adipocytes) and FoxO1 is named in the Figure 2 legend as one of insulin's transcriptional arms. doi 10.3389/fphys.2022.826314 · PMC6792037
What it drives
It reduces Fat-releasing enzyme (ATGL).
'insulin may inhibit lipolysis by decreasing transcription of ATGL via the mTORC1-mediated pathway... OR through FoxO1' (doi 10.3389/fphys.2022.826314). A third, parallel route to the same gene. doi 10.3389/fphys.2022.826314
It increases The Factory Order.
10.26508/lsa.201900506 — PMID 21356515 — IRF4 is induced in fasting adipose tissue and that rise is controlled by insulin and its downstream factor FoxO1 (ライフサイエンス 新着論文レビュー (first.lifesciencedb.jp/archives/2444)). ⇒ fasting raises it; insulin suppresses it. A fourth insulin route into lipolysis alongside PDE3B (erase the messenger), PP1 (activate the eraser) and mTORC1-Egr1 (stop ATGL transcription) — and the one that best explains why this product's own evidence says it must be taken fasted. doi 10.26508/lsa.201900506 · PMID 21356515
Blends that modulate it
Each blend page names this pathway and carries the study behind its claim.
See it on the map
Open the causal map to follow this pathway upstream and downstream, arrow by arrow, each with its study.